Professional Documents
Culture Documents
Female Reproductive Physiology 2021
Female Reproductive Physiology 2021
2021
DR. MASIKA
FEMALE REPRODUCTIVE ORGANS
• Uterus
Uterus is otherwise known as womb. It lies in the pelvic cavity,
in between the rectum and urinary bladder.
• is a hollow muscular organ with a thick wall. It has a central
cavity, which opens into vagina through cervix. On either side at
its upper part, the fallopian tubes open.
• communicates with peritoneal cavity through fallopian tubes.
Virgin uterus is pyriform in shape and is flattened antero-
posteriorly. It measures about 7.5 cm in length, 5 cm in breadth
at its upper part and about 2.5 cm in thickness.
• There is a constriction almost at the middle of uterus called
isthmus.
Divisions of uterus
2. Effects on metabolism
i. Protein metabolism
- Oestrogens cause positive nitrogen balance due to growth promoting
effect which causes slight increase in the total body proteins.
- Oestrogens also increase the he
- Oestrogens also increase the hepatic synthesis of certain circulating
proteins, such as: thyroxine binding globulin, cortisol binding
globulins, renin substrate, angiotensinogens, very low density
lipoproteins (VLDL),and high density lipoproteins.
ii. Fat metabolism
- Oestrogens cause fat deposition in subcutaneous tissues, in the
breasts and the thighs.
- Lower the plasma cholesterol level and low density lipids due to
increase in number of LDL receptors.
3. Water and electrolyte balance. Oestrogens like other steroids in
general, cause salt and water retention in the body and produce
premenstrual tension in some women.
II. Other actions cont’
4. Effects on vasculature. In general oestrogens have vasodilator and anti-vasoconstrictor effects.
• The vasodilator effect is through local release of vasodilator substances like nitric oxide (NO),
prostaglandins E2 and prostacyclin, and
• The antivasoconstrictor effect is through inhibition of endothelin-1 release (a vasoconstrictor
agent).
• Note: At the end of luteal phase of menstrual cycle there is sudden fall in plasma concentration
of oestrogen which results in alterations in the balance of vasodilatation and anti
vasconstriction and thus initiates ischaemic necrosis during menstrual phase.
• Loss of vasodilator effect in postmenopausal women leads to increased risk of coronary heart
disease.
5. Effects on CNS: Oestrogens are responsible for oestrous behaviour in animals and also increase
the libido in human females
• Oestrogens also act on other areas of the brain and effect the neuronal discharge and thus
effect the brain functioning. It has been observed that in mice oestrogen improves the memory
and learning. Therefore, deficiency of oestrogen in postmenopausal women is associated with
defects in declarative memory and development of Alzheimer’s disease.
6. Effects on skin: Oestrogens make the skin soft and more vascular.
• It makes the sebaceous glands secretions thin and inhibits formation of black heads
(comedones) and acne. Therefore, synthetic oestrogens are used as a part of treatment in acne
• i. Hair distribution: Hair develops in the pubic region and axilla. In
7. E ffect onSec ondar ySexu alChara cters
females, pubic hair has the base of the triangle upwards. Body hair
growth is less. Scalp hair grows profusely
ii. Skin:Skin becomes soft and smooth. Vascularity of skin also
increases
iii. Body shape: Shoulders become narrow, hip broadens, thighs
converge and the arms diverge. Fat deposition increases in breasts
and buttocks
iv. Pelvis: a. Broadening of pelvis with increased transverse diameter; b.
Round or oval shape of pelvis
• c. Round or oval=shaped pelvic outlet. Thus, pelvis in females is
different from that of males, which is funnel shaped.
• iv. Voice: Larynx remains in prepubertal stage, which produces
high-pitch voice.
Effect on Uterus
i. Enlargement of uterus to about double of its childhood size due to the proliferation of
endometrial cells
ii. Increase in the blood supply to endometrium
iii. Deposition of glycogen and fats in endometrium
iv. Proliferation and dilatation of blood vessels of endometrium
v. Proliferation and dilatation of the endometrial glands, which become more tortuous with
increased blood flow
vi. Increase in the spontaneous activity of the uterine muscles and their sensitivity to
oxytocin
vii. Increase in the contractility of the uterine muscles. All these changes prepare uterus for
pregnancy.
Effect on Breast
• Oestrogens act by entering into the cell and then bind with cytoplasmic receptors.
Oestrogen receptors: Oestrogen receptors are of two types (ERα and ERβ) and are coded by two
different genes located on separate chromosomes.
• The oestrogen receptor α (ERα) are mainly present in the endometrium, breasts, pituitary gland
and adrenal glands, and in the testes and epididymis in males. Whereas oestrogen
receptors β (ER β) are located in the ovaries (granulosa cells), bones (osleoclasts), lungs, some
areas of brain and in prostate gland and urinary bladder in males.
• It has been suggested that the actions of oestrogen which are carried out by circulatory
oestrogens and through hypothalamo-pituitary-gonadal axis are mainly mediated through ERα
receptors and the actions of oestrogen present in the follicular antrum are mediated through
ERβ receptors.
• The receptors contain a heat shock protein (HSP). When oestrogen binds to the receptor the HSP
get displaced and oestrogen receptor complex so formed is transferred on to the nucleus of the
target cell.
• Then the oestrogen receptor get bound to oestrogen response element present on the DNA
molecule
• Promotes the synthesis of new mRNA and that in turn directs the synthesis of new proteins
which modify the target cell activity.
• Note. Most of the actions of oestrogens are mediated via genomic receptors (ERα and ERβ).
However, some of its effects are so rapid (e.g. effect on brain neuronal discharge and feedback
effect on gonadotropins release that they might be mediated through non-genomic receptors
present on the plasma membrane.
Synthetic oestrogens
1. Action on uterus:
i. is responsible for the secretory phase of the endometrial cycle and
prepares the endometrium to receive the zygote. It decreases the
uterine motility by:
a. It decreases the synthesis of voltage-dependent Ca2+ channel
proteins, therefore Ca2+ uptake decreases.
b. It decreases the number of oestrogen receptors on the myometrium.
ii. Increases the thickness of the endometrium by increasing the
number and size of the cells. Thickness of endometrium increases
from 1 mm thickness at the beginning of secretory phase to about 5
to 6 mm at the end of secretory phase.
iii. Increases the size of uterine glands and these glands become more
tortuous
iv. Increases the secretory activities of epithelial cells of uterine glands
1. Action on uterus cont’
iv. Increases the deposition of lipid and glycogen in
the stromal cells of endometrium
v. Increases the blood supply to endometrium. It is
due to increase in size of the vessels and
vasodilatation
vi. Decreases the frequency of uterine contractions
during pregnancy. Because of this, the expulsion of
the implanted ovum is prevented.
Me cha nis m of acti on
• The effects of the progesterone on its target cell is achieved by acting through its
receptors.
• The progesterone receptors are present in the cytoplasm of the target cells and
contain a protein called HSP.
• Being lipid progesterone easily enters through bilayer lipid membrane and
combines with its receptors.
• Then the HSP displaces and thus exposing the DNA binding site.
• Then the receptor progesterone complex get transferred on to the nucleus and
binds to a specific site on the DNA molecule, and
• Initiates encoding of gene expression to form new mRNA. The mRNA then directs
the apparatus to form new proteins (enzymes and structural proteins) which modify
the activities of the target cells.
Note. A synthetic steroid mifepristone (RU-486) binds to progesterone receptors and
blocks the DNA binding site. Therefore this drug acts as aantiprogesterone drug.
Synthetic preparations of progesterone. Various synthetic preparations are available
under the name prostagens and gestagens. Therapeutically these drugs are used in:
• Inevitable abortion
• As contraceptives when used along with oestrogens.
O th er o va ria n h orm one s
• Besides female sex steroids (oestrogen and progesterone) ovaries also secrete
peptide hormones as:
1. Inhibin structurally it is polypeptide, it inhibits the FSH release.
2. Activin. Structurally, it is also a polypeptide; its action is to activate FSH
secretion from anterior pituitary.
3. Relaxin is a polypeptide hormone produced by corpus luteum and other sites
include: uterus, placenta and mammary glands and in males from the prostate
gland. Its main role is during pregnancy as mentioned:
• It relaxes pubic symphysis and pelvic joints, softens and dilates the uterine
cervix and facilitates delivery.
• In non-pregnant state it releases from the corpus luteum and endometrium
during secretory phase its function is not known.
• In males relaxin is present in the semen and helps in sperm motility and
penetration of ovum by the sperm.
4. Ovarian androgens. A small amount of testosterone is also secreted by the
ovaries during biosynthesis of oestrogen and progesterone, but the main source
of androgens in female is adrenal cortex. These androgens are responsible for
acne vulgaris, libido, and pubic hair.
• Is cyclic events that take place in a rhythmic fashion during the
M ENS TR U AL C YC LE
• 1. Primordial follicle
2. Primary follicle
3. Vesicular follicle
4. Matured follicle or graafin follicle.
1. Primordial Follicle